Skip to content
10-K

Annual Report

Arcturus Therapeutics Ltd.

0001564590-19-008092

← back to feed
Filed
Mar 18, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 1, 2019 10.76M sh
Dividends Paid FY 2018 · Dec 31, 2018 $0
Dividends Paid FY 2018 · Dec 31, 2017 $0
Capex FY 2018 · Dec 31, 2018 $1.48M
Capex FY 2018 · Dec 31, 2017 $251K
Operating Cash Flow FY 2018 · Dec 31, 2018 −$20.76M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$460K
Long Term Debt FY 2018 · Dec 31, 2018 $9.91M
Cash And Equivalents FY 2018 · Dec 31, 2018 $36.71M
Cash And Equivalents FY 2018 · Dec 31, 2017 $24.97M
Stockholders Equity FY 2018 · Dec 31, 2018 $13.64M
Stockholders Equity FY 2018 · Dec 31, 2017 $33.79M
Stockholders Equity restated FY 2018 · Dec 31, 2016 $1.58M
Current Liabilities FY 2018 · Dec 31, 2018 $12.58M
Current Liabilities FY 2018 · Dec 31, 2017 $11.04M
Total Liabilities FY 2018 · Dec 31, 2018 $30.56M
Total Liabilities FY 2018 · Dec 31, 2017 $18.23M
Current Assets FY 2018 · Dec 31, 2018 $41.83M
Current Assets FY 2018 · Dec 31, 2017 $50.87M
Total Assets FY 2018 · Dec 31, 2018 $44.2M
Total Assets FY 2018 · Dec 31, 2017 $52.02M
Sga Expense FY 2018 · Dec 31, 2018 $20.58M
Sga Expense FY 2018 · Dec 31, 2017 $7.57M
Rd Expense FY 2018 · Dec 31, 2018 $16.98M
Rd Expense FY 2018 · Dec 31, 2017 $15.92M
Net Income FY 2018 · Dec 31, 2018 −$21.79M
Net Income FY 2018 · Dec 31, 2017 −$10.9M
Operating Income FY 2018 · Dec 31, 2018 −$21.81M
Operating Income FY 2018 · Dec 31, 2017 −$10.49M
Short Term Investments FY 2018 · Dec 31, 2017 $23.61M